Dr. Jack Cush – Rheumatology Round-Up at ACR 17
Dr. Arthur Kavanaugh: ACR Wrap-Up
IL-17–producing αβ T cell clones with psoriasis-specific antigen receptors exist in clinically resolved psoriatic skin lesions and represent the disease-initiating pathogenic T cells in psoriasis. https://t.co/AejfC23Jse
— Dr. John Cush (@RheumNow) November 16, 2017
Dr. Philip Mease: Risankizumab in PsA
Check out Phil Mease's ACR17 video on Risankizumab (an IL-23 inhibitor) in Psoriatic arthritis –
this was a late breaking abstract in San Diego https://t.co/7SuyUP1SaY— Dr. John Cush (@RheumNow) November 16, 2017
Abbvies 9/17 settlement with Amgen that allows Amgens adalimumab biosimilar (Amjevita) to begin sales in EU Oct 2018 and in the USA in 2023 is estimated to cost the US Centers of Medicare and Medicaid (CMS) at least US$1.48 billion in savings. https://t.co/sbc9TyFmR6
— Dr. John Cush (@RheumNow) November 16, 2017
FDA issues a Safety Alert over FEBUXOSTAT and increased risk of Cardiac Death (compared to allopurinol users). This is based on comparative 6000 pt safety trial wherein Febuxostat showed an increased risk of heart-related deaths and death from all causes. https://t.co/kCEt1Sn6WR
— Dr. John Cush (@RheumNow) November 15, 2017
VOLTAIRE-RA Study presented at #ACR17 shows efficacy & safety equivalence between Humira (adalimumab) and new FDA approved biosimilar adalimumab-abdm (Cyltezo). Also showed sustained responses when pts switched from Humira to Cyltezo https://t.co/Ia5ZmsW8iG
— Dr. John Cush (@RheumNow) November 14, 2017
Smoking Paradox in PsA – a UK study shows smoking was positively related to PsA risk in the general population, but negatively associated with PsA risk among patients with psoriasis. https://t.co/gbYaotcrtS
— Dr. John Cush (@RheumNow) November 14, 2017
Review from 🇨🇳: Icariin, a flavonoid with bone-promoting activity effective in postmenopausal OP in 24mo trial. Proposed mechanism: stimulating osteogenic differentiation of BMSCs&osteoclastogenic differentiation. @RheumNow https://t.co/g7yj8drnDJ
— Olga Petryna (@DrPetryna) November 13, 2017
Metanalysis of 6 studies, 7908 controls and 2899 cases, showed that vitamin C intake was associated with lower risk of hip fracture [OR = 0.73, 95% CI = 0.55-0.97]. A 50 mg/d increase in vitamin C intake statistically reduced by hip Fx risk by 5% https://t.co/p9rJ4Si3hz
— Dr. John Cush (@RheumNow) November 13, 2017
Check out Dr. Eric Rudermans #ACR17 video on the impact of Prior Authorizations thru a specialty pharmacy. https://t.co/SSi2WkPGap
— Dr. John Cush (@RheumNow) November 13, 2017
This is the single best source on Biologics for Patients – Download the Patient Guide to Biologics from RheumNow. 6 pages of overview/comparisons and 5 single drug pages for 1) TNF drugs; 2) Anakinra; 3) Rituximab; 4) Tocilizumab and 5) Abatacept. https://t.co/5Omln4dGZi
— Dr. John Cush (@RheumNow) November 13, 2017
Pregabalin (not duloxetine) improves pain in hand osteoarthritis in RCT vs PBO – improved pain and function. https://t.co/Hio2wfWLKx
— Dr. John Cush (@RheumNow) November 13, 2017
The RheumNow ACR17 Wk in Review is up! Cush reviews highlights from last weeks Annual ACR meeting in San Diego. Watch the video or do the podcast on iTunes or SoundHound soundcloud.comrheumnow/the-rheumnow-week-in-review-10-november-2017
— Dr. John Cush (@RheumNow) November 11, 2017
Learn about the benefits of master #datamanagement in #pharma product development. Download our latest report: https://t.co/sY66Xb0335
— Deloitte Health Care (@DeloitteHealth) November 11, 2017
Fentanyl, not heroin, drove 2016 surge in drug-overdose deaths, C.D.C. says. https://t.co/5LH0z5rtcz
— NYT Health (@NYTHealth) November 11, 2017
Check out my book – 'The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families (A …' – on #BookBuzz – https://t.co/hvnoFRzLAa
— Donald Thomas, MD (@lupuscyclopedia) November 11, 2017
Predictors of radiographic progression in patients with nr-axSpA: conclusions from DESIR trial – R. Landewé SPARTAN-ASAS-GRAPPA symposium #ACR17 pic.twitter.com/WgqGOUYL5k
— Marco S Massarotti (@msmassarotti) November 8, 2017
Spoke w OMB and suggested Part D pts pay coinsurance on discounted price not list price.longer to get into catastrophic saves $ https://t.co/74meKnoeac
— Madelaine Feldman (@MattieRheumMD) November 10, 2017
EULAR & ACR present draft of new #SLE Classification Criteria at the 2017 ACR/ARHP Annual Meeting.→ https://t.co/PaviXkg9BT #ACR17
— AmerCollRheumatology (@ACRheum) November 6, 2017
New SLE classification criteria #ACR17 pic.twitter.com/otKBP5ixyx
— dr hanady manasfi (@hanadymanasfi) November 7, 2017
Bone marrow oedema in sacroiliac joints is common (30-40%) in young athletes and is most frequent in the posterior lower ilium #ACR17 Weber
— Dr. Antoni Chan (@synovialjoints) November 6, 2017
Only 9-14% people with chronic backache see a rheumatologist #ACR17 pic.twitter.com/jq5Y0xFjE6
— Dr. shashank akerkar (@doctorakerkar) November 6, 2017
drug induced ANCA associated vasculitis #ACR17 pic.twitter.com/3N7La0WS5x
— Suleman Bhana, MD (@DrBhana) November 4, 2017
Our abstract was thought to be top 3 at #ACR2017 #greatful https://t.co/qUOr486Cxn
Thank you @RheumNow @rheumroundup— Bella Mehta (@bella_mehta) November 10, 2017
PulmHTN and ILD now leading cause of death in #scleroderma #GR pic.twitter.com/6q2i9yWdB8
— Isabelle Amigues (@isa75012) November 9, 2017
Great #ACR2017 in San Diego. Looking forward to the 5th Systemic Sclerosis World Congress #EUSTAR pic.twitter.com/JOgCxU22z5
— Anna Hoffmann-Vold (@hoffmann_vold) November 9, 2017
My favorite memento from #ACR17 in San Diego: I got my Rheumatology Secrets book (kinda) autographed by Dr. Sterling West. It reads "Good Luck in Your Career. Stop Winning Rheum Knowledge Bowls!" pic.twitter.com/GVrLOlMsRC
— Bharat Kumar (@BharatKumarMD) November 10, 2017
2017 EULAR/ACR #myositis classification criteria – now in A&R as well https://t.co/KuQS98kdRU
— Hector Chinoy (@drhectorchinoy) November 10, 2017
Diabetes associated with fractures in older male veterans, with comorbidities as mediating factors https://t.co/DA5Xf4JQSz
— ACP Internist (@acpinternist) November 10, 2017
There are more pearls to providing excellent patient care on this slide than I thought possible! Practice these and you will be a god among mortals https://t.co/gYS3BT1xg3 More great work from @nate_houchens @sanjaysaint pic.twitter.com/URjxeGy3bR
— Charlie M. Wray (@WrayCharles) November 9, 2017
CVD risk in axSpA – Nigil Haroon SPARTAN-GRAPPA-ASAS Symposium #ACR17 pic.twitter.com/BtpXBszcUb
— Marco S Massarotti (@msmassarotti) November 8, 2017
#Osteoporosis pts with GI problems less likely to be adherent to OP Rx. Mostly seen w/ #bisphosphonates Rx. Experienced users more likely to continue Rx (76.1%) compared with new users (66.7%). https://t.co/QEpwcsp3Hb… @RheumNow @OsteoporosisNOF @iofbonehealth pic.twitter.com/ZcxUW3L5tu
— Olga Petryna (@DrPetryna) November 10, 2017
Check out Dr. Jane Popes Video on #RA and Interstitial Lung Disease from #ACR17. https://t.co/2QnNjBYFZf
— Dr. John Cush (@RheumNow) November 9, 2017
Agree. Only 6% were strong recommendations. Glad they addressed comorbidities but management not necessarily consistent with my current practice pic.twitter.com/reUg9ktFwS
— Julio Gonzalez (@japaoli19) November 9, 2017
New PsA guideline expected in 2018. #ACR17 https://t.co/c7Y8GiBv4q pic.twitter.com/g7wtIBXXko
— Rheumatology News (@rheumnews1) November 9, 2017
Good morning! Penultimate day at #ACR17 more learning and discussion, good connection, Wi-fi, excellent app @ACRheum #rheum pic.twitter.com/EXUuSFPfxw
— Dr. Antoni Chan (@synovialjoints) November 7, 2017
Check out my video from #ACR17 on Still's disease and Autoinflammatory Syndromes – from Bedside to Bench. https://t.co/HE9UDOL9ft
— Dr. John Cush (@RheumNow) November 9, 2017
Big Take Home Message from #ACR17 on influenza vaccination- AT Next MTX FUV- give the flu vaccine AND HOLD MTX for 2 weeks (Plenary Session) by Park et al. https://t.co/grfLQx0CYN pic.twitter.com/A3xOyZOu5m
— Dr. John Cush (@RheumNow) November 9, 2017
New #review online now!
Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritishttps://t.co/vXggM2gcuO #SharedIt #osteoarthritis #stemcells #cartilage pic.twitter.com/3ypnVurcVP— NatRevRheumatol (@NatRevRheumatol) November 9, 2017
High #cardiovascular disease risk in autoimmune inflammatory #rheumatic conditions
Assess & treat CV risks
via @cgytz #ACR17#cardiac pic.twitter.com/MQ36FJRU1E— Dr Ai Lyn Tan (@DrAiLynTan) November 7, 2017
Brush up on your knowledge & test-taking skills while earning CME & MOC points! Learn about CARE 2017 → https://t.co/i703h0AREA #rheumedu pic.twitter.com/NWko479htn
— AmerCollRheumatology (@ACRheum) November 9, 2017
Such a Debbie downer Nicola #ACR17 https://t.co/4uthPUXjsg
— Philip Robinson (@philipcrobinson) November 9, 2017
Smoking paradox: smoking assoc w/⬆️risk of PsA in gen population HR1.27 but w/ ⬇️risk of PsA in PSO (HR 0.91) population-based study concludes https://t.co/TfKFThRsJX @RheumNow
— Olga Petryna (@DrPetryna) November 9, 2017
Big Take Home Message from #ACR17 on influenza vaccination- AT Next MTX FUV- give the flu vaccine AND HOLD MTX for 2 weeks (Plenary Session) by Park et al. https://t.co/grfLQx0CYN pic.twitter.com/A3xOyZOu5m
— Dr. John Cush (@RheumNow) November 9, 2017
Dr. Shashank Akerkar: New Molecules in Psoriatic Arthritis
Dr Jack Cush: Stills and Auto-Inflammatory Syndromes